Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Identification and Quantification of MIDD0301 Metabolites.
Journal: Current drug metabolism
Published: June 13, 2021
Correction to "A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABAA Receptors in the Lung".
Journal: Molecular pharmaceutics
Published: October 22, 2019
A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABAA Receptors in the Lung.
Journal: Molecular pharmaceutics
Published: March 27, 2018
Alleviation of Multiple Asthmatic Pathologic Features with Orally Available and Subtype Selective GABAA Receptor Modulators.
Journal: Molecular pharmaceutics
Published: April 26, 2017
Optimization of substituted imidazobenzodiazepines as novel asthma treatments.
Journal: European journal of medicinal chemistry
Published: October 01, 2016
Development of GABAA Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma Treatments.
Journal: Molecular pharmaceutics
Published: April 28, 2016
Identification of a novel, fast-acting GABAergic antidepressant.
Journal: Molecular psychiatry
Published: April 21, 2016
Antitumor Activity of 3-Indolylmethanamines 31B and PS121912.
Journal: Anticancer research
Published: October 28, 2015
Rapid quantification of imidazolium-based ionic liquids by hydrophilic interaction liquid chromatography: Methodology and an investigation of the retention mechanisms.
Journal: Journal of chromatography. A
Published: October 30, 2014
Anticancer activity of VDR-coregulator inhibitor PS121912.
Journal: Cancer chemotherapy and pharmacology
Published: January 23, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026